Direct comparison of [18F]MH.MZ and [18F]altanserin for 5-HT2A receptor imaging with PET

Synapse

Volumn 67, Issue 6, 2013, Pages 328-337

  Hansen, Hanne D ^a   Ettrup, Anders ^a   Herth, Matthias M ^a   Dyssegaard, Agnete ^a   Ratner, Cecilia ^a   Gillings, Nic ^a   Knudsen, Gitte M ^a  

^a Rigshospitalet   (Denmark)

Author keywords

5 HT2A receptor; 18F altanserin; 18F MH.MZ; Autoradiography; MDL 100907; PET

Indexed keywords

ALTANSERIN F 18; KETANSERIN; MH.MZ F 18; PRAZOSIN; RACLOPRIDE; RADIOPHARMACEUTICAL AGENT; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; VOLINANSERIN;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; KINETICS; LIPOPHILICITY; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; SWINE;

ANIMALS; BRAIN; FLUORINE RADIOISOTOPES; FLUOROBENZENES; KETANSERIN; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN ANTAGONISTS; SWINE; TISSUE DISTRIBUTION; TRITIUM;

EID: 84876438817     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21643     Document Type: Article

References (30)

1. Adams KH, Pinborg LH, Svarer C, Hasselbalch SG, Holm S, Haugbol S, Madsen K, Frokjaer V, Martiny L, Paulson OB, Knudsen GM. 2004. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: Normative data and relationship to physiological and demographic variables. Neuroimage 21:1105-1113.
2. Biver F, Lotstra F, Monclus M, Dethy S, Damhaut P, Wikler D, Luxen A, Goldman S. 1997. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: A film and electronic autoradiographic study. Nucl Med Biol 24:357-360.
3. Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN. 2010. Measuring drug occupancy in the absence of a reference region: The Lassen plot re-visited. J Cereb Blood Flow Metab 30:46-50.
4. Debus F, Herth MM, Piel M, Buchholz HG, Bausbacher N, Kramer V, Luddens H, Rosch F. 2010. 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging. Nucl Med Biol 37:487-495.
5. Ettrup A, Palner M, Gillings N, Santini MA, Hansen M, Kornum BR, Rasmussen LK, Nagren K, Madsen J, Begtrup M, Knudsen GM. 2010. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET. J Nucl Med 51:1763-1770.
6. Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, Lehel S, Herth MM, Madsen J, Kristensen J, Begtrup M, Knudsen GM. 2011a. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers. Eur J Nucl Med Mol Imaging 38:681-693.
7. Ettrup A, Kornum BR, Weikop P, Knudsen GM. 2011b. An approach for serotonin depletion in pigs: Effects on serotonin receptor binding. Synapse 65:136-145.
8. Gillings N. 2009. A restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma. Nucl Med Biol 36:961-965.
9. Hall H, Farde L, Halldin C, Lundkvist C, Sedvall G. 2000. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907. Synapse 38:421-431.
10. Hasselbalch SG, Madsen K, Svarer C, Pinborg LH, Holm S, Paulson OB, Waldemar G, Knudsen GM. 2008. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment. Neurobiol Aging 29:1830-1838.
11. Herth MM, Debus F, Piel M, Palner M, Knudsen GM, Luddens H, Rosch F. 2008. Total synthesis and evaluation of [18F]MHMZ. Bioorg Med Chem Lett 18:1515-1519.
12. Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rosch F. 2009a. Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET. Bioorg Med Chem 17:2989-3002.
13. Herth MM, Piel M, Debus F, Schmitt U, Luddens H, Rosch F. 2009b. Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [(18)F]MH.MZ. Nucl Med Biol 36:447-454.
14. Herth MM, Kramer V, Gillings N, Rösch F, Knudsen GM. 2012. Direct radiofluorination of [18F]MH.MZ for 5-HT2A receptor molecular imaging with PET. J Label Comp Rad 55:354-358.
15. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539.
16. Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, Frank RA, van Giersbergen PL, McCloskey TC, Johnson MP, McCarty DR, Poirot M, Senyah Y, Siegel BW, Widmaier C. 1996. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100, 907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968-981.
17. Kornum BR, Lind NM, Gillings N, Marner L, Andersen F, Knudsen GM. 2009. Evaluation of the novel 5-HT4 receptor PET ligand [11C]SB207145 in the Gottingen minipig. J Cereb Blood Flow Metab 29:186-196.
18. Leysen JE. 1989. Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites. In: Boulton A, Baker G, Juorio A, editors. Drugs as tools in neurotransmitter research: Humana Press, New York, USA. p 299-350.
19. Lopez-Gimenez JF, Mengod G, Palacios JM, Vilaro MT. 1997. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100, 907. Naunyn Schmiedebergs Arch Pharmacol 356:446-454.
20. McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D. 1987. 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord 13:67-74.
21. Naughton M, Mulrooney JB, Leonard BE. 2000. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol Clin Exp 15:397-415.
22. Paterson LM, Kornum BR, Nutt DJ, Pike VW, Knudsen GM. 2011. 5-HT radioligands for human brain imaging with PET and SPECT. Med Res Rev 2013;33:54-111.
23. Pinborg LH, Adams KH, Svarer C, Holm S, Hasselbalch SG, Haugbol S, Madsen J, Knudsen GM. 2003. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. J Cereb Blood Flow Metab 23:985-996.
24. Price JC, Lopresti BJ, Mason NS, Holt DP, Huang Y, Mathis CA. 2001a. Analyses of [(18)F] altanserin bolus injection PET data. I: Consideration of radiolabeled metabolites in baboons. Synapse 41:1-10.
25. Price JC, Lopresti BJ, Meltzer CC, Smith GS, Mason NS, Huang Y, Holt DP, Gunn RN, Mathis CA. 2001b. Analyses of [(18)F]altanserin bolus injection PET data. II: Consideration of radiolabeled metabolites in humans. Synapse 41:11-21.
26. Rasmussen H, Erritzoe D, Andersen R, Ebdrup BH, Aggernaes B, Oranje B, Kalbitzer J, Madsen J, Pinborg LH, Baare W, Svarer C, Lublin H, Knudsen GM, Glenthoj B. 2010. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry 67:9-16.
27. Scott DO, Heath TG. 1998. Investigation of the CNS penetration of a potent 5-HT2a receptor antagonist (MDL 100, 907) and an active metabolite (MDL 105, 725) using in vivo microdialysis sampling in the rat. J Pharm Biomed Anal 17:17-25.
28. Tan P-Z, Baldwin RM, Fu T, Charney DS, Innis RB. 1999. Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2a receptors. J Label Comp Rad 42:457-467.
29. Watabe H, Channing MA, Der MG, Adams HR, Jagoda E, Herscovitch P, Eckelman WC, Carson RE. 2000. Kinetic analysis of the 5-HT2A ligand [11C]MDL 100, 907. J Cereb Blood Flow Metab 20:899-909.
30. Watanabe H, Andersen F, Simonsen CZ, Evans SM, Gjedde A, Cumming P. 2001. MR-based statistical atlas of the Gottingen minipig brain. Neuroimage 14:1089-1096.